Myomo, Inc. (MYO) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Myomo, Inc. (MYO).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.67

Daily Change: $0.00 / 0.00%

Daily Range: $0.615 - $0.70

Market Cap: $25,802,850

Daily Volume: 482,946

Performance Metrics

1 Week: -1.62%

1 Month: -16.74%

3 Months: -26.37%

6 Months: -26.79%

1 Year: -86.33%

YTD: -26.37%

Company Details

Employees: 195

Sector: Distribution services

Industry: Medical distributors

Country: United States

Details

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Selected stocks

MEDIROM Healthcare Technologies Inc. (MRM)

OS Therapies Incorporated (OSTX)

Core AI Holdings, Inc. (CHAI)